Details
Stereochemistry | ACHIRAL |
Molecular Formula | C22H23N5O2 |
Molecular Weight | 389.4503 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1(C)CN(C1)C(=O)C2=CC=C(C=C2)C3=CC=CC4=NC(NC(=O)C5CC5)=NN34
InChI
InChIKey=MPYACSQFXVMWNO-UHFFFAOYSA-N
InChI=1S/C22H23N5O2/c1-22(2)12-26(13-22)20(29)16-10-6-14(7-11-16)17-4-3-5-18-23-21(25-27(17)18)24-19(28)15-8-9-15/h3-7,10-11,15H,8-9,12-13H2,1-2H3,(H,24,25,28)
Solcitinib (also known as GSK2586184 or GLPG0778) is a selective Janus kinase 1 (JAK1) inhibitor, for the treatment of psoriasis, lupus, and ulcerative colitis. Galapagos NV's collaboration with GlaxoSmithKline has hit a roadblock. It was reported that its Big Pharma partner had hit the brakes on a Phase II study of GSK2586184 for lupus after a first look at the data failed to demonstrate a positive effect. And an exploratory Phase I/II of the same drug for ulcerative colitis was put on hold as investigators review the program.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2835 Sources: https://www.ncbi.nlm.nih.gov/pubmed/?term=25724932 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Palliative | Unknown Approved UseUnknown |
|||
Palliative | Unknown Approved UseUnknown |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1967
Created by
admin on Sat Dec 16 08:19:37 GMT 2023 , Edited by admin on Sat Dec 16 08:19:37 GMT 2023
|
||
|
NCI_THESAURUS |
C574
Created by
admin on Sat Dec 16 08:19:37 GMT 2023 , Edited by admin on Sat Dec 16 08:19:37 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
10047
Created by
admin on Sat Dec 16 08:19:37 GMT 2023 , Edited by admin on Sat Dec 16 08:19:37 GMT 2023
|
PRIMARY | |||
|
C152385
Created by
admin on Sat Dec 16 08:19:37 GMT 2023 , Edited by admin on Sat Dec 16 08:19:37 GMT 2023
|
PRIMARY | |||
|
3V7GQ1260K
Created by
admin on Sat Dec 16 08:19:37 GMT 2023 , Edited by admin on Sat Dec 16 08:19:37 GMT 2023
|
PRIMARY | |||
|
44603362
Created by
admin on Sat Dec 16 08:19:37 GMT 2023 , Edited by admin on Sat Dec 16 08:19:37 GMT 2023
|
PRIMARY | |||
|
100000174858
Created by
admin on Sat Dec 16 08:19:37 GMT 2023 , Edited by admin on Sat Dec 16 08:19:37 GMT 2023
|
PRIMARY | |||
|
1206163-45-2
Created by
admin on Sat Dec 16 08:19:37 GMT 2023 , Edited by admin on Sat Dec 16 08:19:37 GMT 2023
|
PRIMARY | |||
|
CHEMBL3301606
Created by
admin on Sat Dec 16 08:19:37 GMT 2023 , Edited by admin on Sat Dec 16 08:19:37 GMT 2023
|
PRIMARY | |||
|
BC-49
Created by
admin on Sat Dec 16 08:19:37 GMT 2023 , Edited by admin on Sat Dec 16 08:19:37 GMT 2023
|
PRIMARY |
ACTIVE MOIETY